JPRN-UMIN000033745招募中未知
Determination of CYP3A activity in patients using plasma amlodipine exposure and metabolism - Determination of CYP3A activity using plasma amlodipine exposure and metabolism
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients from whom written informed consent was not obtained
研究者
相似试验
招募中
不适用
A non-interventional study to assess CYP3A induction by high-dose systemic glucocorticoids and by mitotane using 4ß-hydroxycholesterol as a biomarkerAny disease, which requires a therapy with high-dose prednisolone/prednisone, dexamethasone, a biological immunosuppressive therapy (patients with autoimmune/chronic inflammatory diseases) OR with an indication to start a therapy with mitotane (adrenocortical carcinoma patients)DRKS00018093Institut I für Pharmakologie,Universitätsklinikum Köln (AöR)64
已完成
不适用
Phenotyping study of the CYP3A4 activity in patients with prostate cancer versus male patients with other types of solid tumours with midazolamprostate cancer and other types of solid tumours10027655NL-OMON51249Antoni van Leeuwenhoek Ziekenhuis18
已完成
不适用
Studying the relationship between the CYP3A and CYP2D6 probe dextromethorphan and the pharmackinetics of tamoxifen.10006291breast cancerNL-OMON33769Erasmus MC, Universitair Medisch Centrum Rotterdam37
进行中（未招募）
1 期
An open-label Phase I Trial of the CYP3A Inhibitor Cobicistat and the cytostatics Gemcitabine and nab-Paclitaxel in Patients with Advanced Stage or metastatic Pancreatic Ductal Adenocarcinoma to evaluate the combination's Pharmacokinetics, Safety and Efficacy (IntenSify).C25.3Pancreatic ductDRKS00029409Deutsches Krebsforschungszentrum6
已完成
不适用
CYP3A activity during nontuberculous mycobacterium infectioontuberculous Mycobacterial Lung DiseaseJPRN-UMIN000027308Hamamatsu university school of medicine Second division, depertment of internal medicine20